Fig. 2From: The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spineOdds ratios and 95% CI of the univariate and sex-adjusted logistic regression of patient status (vertebral osteomyelitis vs. control patients) with respect to suPAR (a) and CRP (b) each stratified by the interval pre-OP, post-OP, and all post-OP intervals combined (overall post-OP)Back to article page